Skip to main content

News and blog posts

22
Mar 2018

Med Tech-related technology assessments and clinical guidelines from NICE in the first half of March 2018

In the first half of March, the National Institute for Health and Care Excellence (NICE) published two new Interventional Procedures Guidance (laparoscopic mesh pectopexy for apical prolapse of the uterus or vagina and mosaicplasty for symptomatic articular cartilage defects of the knee) and one new Technology appraisal guidance for autologous chondrocyte implantation using chondrosphere for treating symptomatic articular cartilage defects of the knee.
21
Mar 2018

Institute for Quality and Efficiency in Health Care (IQWiG) released the final report on telemonitoring with active cardiac implantable devices for ventricular tachyarrhythmias and heart failure

The Institute for Quality and Efficiency in Health Care (IQWiG) released the final report on the assessment of benefit for telemonitoring of cardiac implantable electronic devices compared to a standard treatment without telemonitoring in patients with ventricular tachyarrhythmias and / or heart failure. It was concluded that the benefits of the telemonitoring for patients with cardiac failure or heart rhythm disorders with a fast heart rate remain unclear.
15
Mar 2018

The guideline on minimally invasive heart valve interventions will be evaluated by the Institute for Quality Assurance and Transparency in Health Care (IQTIG) in Germany

The German Federal Joint Committee (G-BA) has commissioned the Institute for Quality Assurance and Transparency in Health Care (IQTIG) to evaluate the guideline on minimally invasive heart valve interventions with minimum quality standards for hospitals that want to perform transcatheter aortic valve implantation (TAVI) or clip procedures on the mitral valve. The report has to be submitted by December, 2019.
09
Mar 2018

National Board of Health and Welfare do not recommend screening for prostate cancer with PSA samples with or without other supplementary tests before tissue sampling

According to the recommendation of the National Board of Health and Welfare (Socialstyrelsen), hospitals and clinics should not offer screening for prostate cancer with PSA tests with or without other supplementary tests before tissue sampling. The recommendation is based on that the benefit of screening for prostate cancer with PSA tests does not outweigh the negative effects on a population level.
07
Mar 2018

The French National Authority for Health (HAS) published new set of decisions about add-on reimbursement for medical devices in February

In February, HAS published a set of decisions about add-on reimbursement of medical devices that were evaluated by the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS). These decisions concern cardiac pacemakers, devices for aortic root replacement, orthopedic devices (double mobility cups, porous high-density polyethylene implants) and other devices.